Make Faster, Better-Informed M&A Decisions

For Corporate Development & Strategy professionals seeking mergers and acquisitions (M&A) and partnership opportunities, it can be challenging to identify, integrate and analyze relevant and actionable company and marketplace data in a timely manner.

Avanos Medical, a leading MedTech company, confronted this challenge. As documented in a new article, featured on Harvard Business Review (HBR) , the company’s strategists were frustrated by a fragmented approach to market intelligence involving disparate data sources, making it hard to spot viable opportunities and slowing down analysis and decision-making.

“It’s always a challenge to find information on companies in a niche or emerging market,” David Mornhinweg, Avanos Medical’s Director of Corporate Development, told HBR, “and even more challenging to find accurate and current information on potential acquisition targets, including management teams, size and growth.”

Avanos Medical’s solution was to adopt S&P Capital IQ Pro. The comprehensive market intelligence platform transformed the company’s workflows in three key ways:

• Private markets insights: Access to extensive private markets data allowed Avanos to discover emerging technologies and startups in MedTech that had previously flown under the radar.
• Collaboration tools: The AI-powered Document Viewer was one of several tools that enhanced the team’s cooperation and sped its decision-making.
• Aftermarket research: Beyond company-level data, Avanos gained insights into market trends, competitor activities and risks.

Discover how the team found ways to decrease time spent on data gathering and analysis, and how they improved strategic decision-making.  View the case study on Harvard Business Review.